Log in

Start Your Membership Now

Otsuka Pharmaceutical (Otsuka) recently signed a 5-year, $88 million smart-tablet partnership with Proteus Digital Health (Proteus). Digital pills are pharmaceutical dosages that contain an ingestible sensor inside of the pill, allowing medical data to be transmitted after the pill has been consumed.

The collaboration will see the $88 million going from Otsuka to Proteus for the development of a new generation of ingestible sensors. The focus will particularly be on medicines developed for the treatment of mental health issues, including Abilify MyCite, a prescription medicine for the treatment of schizophrenia, bipolar I disorder, and major depressive disorder. Just . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Service & Treatment Updates

Categories
All Bulletins
Submit a Bulletin
  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.